Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 6/20 | 0.47 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GSK3A | P49840 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9540022 | 0.89 | PTGDR2 (0.48) | PTGDR2SCN9ACMA1OPRL1MEN1 | |
| SCHEMBL9539088 | 0.88 | PTGDR2 (0.47) | PTGDR2SCN9ACMA1OPRL1MEN1 | |
| SCHEMBL9542817 | 0.88 | PTGDR2 (0.47) | PTGDR2SCN9ACMA1OPRL1MEN1 | |
| SCHEMBL9539017 | 0.87 | PTGDR2 (0.49) | PTGDR2SCN9ACMA1MEN1ALDH1A1 | |
| SCHEMBL9541601 | 0.87 | PTGDR2 (0.47) | PTGDR2SCN9ACMA1OPRL1MEN1 | |
| SCHEMBL9539049 | 0.87 | PTGDR2 (0.43) | PTGDR2SCN9ACMA1OPRL1MEN1 | |
| SCHEMBL9539735 | 0.86 | PTGDR2 (0.45) | PTGDR2SCN9ACMA1OPRL1MEN1 | |
| SCHEMBL9541633 | 0.85 | PTGDR2 (0.44) | PTGDR2SCN9ACMA1OPRL1 | |
| SCHEMBL9539089 | 0.85 | PTGDR2 (0.51) | PTGDR2SCN9ACMA1OPRL1MEN1 | |
| SCHEMBL9542713 | 0.84 | PTGDR2 (0.44) | PTGDR2SCN9ACMA1OPRL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0530994-A1 | Quinazoline derivatives as inhibitors of HIV reverse transcriptase | MERCK & CO. INC. (US) | 1993-03-10 | — | — | EP | disclosed |
| WO-1993004047-A1 | QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE | MERCK & CO., INC. (US) | 1993-03-04 | — | — | WO | disclosed |